About MyOme
MyOme is a company based in San Carlos (United States) founded in 2017 by Kate Im, Akash Kumar, and Matthew Rabinowitz.. MyOme has raised $23 million across 1 funding round from investors including Healthcare Ventures. MyOme offers products and services including Proactive Health Tests, Diagnostic Tests, and Integrated Polygenic Risk Score. MyOme operates in a competitive market with competitors including InformedDNA, Arivale, GB HealthWatch, Answer Genomics and Dante Labs, among others.
- Headquarter San Carlos, United States
- Founders Kate Im, Akash Kumar, Matthew Rabinowitz
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mycarrier Tms
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23 M (USD)
in 1 rounds
-
Latest Funding Round
$23 M (USD), Series B
Jun 21, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MyOme
MyOme offers a comprehensive portfolio of products and services, including Proactive Health Tests, Diagnostic Tests, and Integrated Polygenic Risk Score. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assesses personal health risks for prevention and treatment decisions.
Provides testing for rare diseases and exome analysis.
Combines factors for personalized risk assessments across ancestries.
Unlock access to complete
Unlock access to complete
Funding Insights of MyOme
MyOme has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series B round of $23 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $23.0M
-
First Round
First Round
(21 Jun 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series B - MyOme | Valuation | Healthcare Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MyOme
MyOme has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Healthcare Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MyOme
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MyOme
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Myome Comparisons
Competitors of MyOme
MyOme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InformedDNA, Arivale, GB HealthWatch, Answer Genomics and Dante Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Network of genetics experts provided to assist patients and providers.
|
|
| domain | founded_year | HQ Location |
Provider of direct-to-consumer genetic testing.
|
|
| domain | founded_year | HQ Location |
Personalized nutrition plans are offered via an online health platform.
|
|
| domain | founded_year | HQ Location |
Online platform offering DNA-based recommendations for health and wellness
|
|
| domain | founded_year | HQ Location |
Whole-genome sequencing analysis is offered for health and wellness insights.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Myome
Frequently Asked Questions about MyOme
When was MyOme founded?
MyOme was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Where is MyOme located?
MyOme is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Is MyOme a funded company?
MyOme is a funded company, having raised a total of $23M across 1 funding round to date. The company's 1st funding round was a Series B of $23M, raised on Jun 21, 2022.
What does MyOme do?
MyOme was founded in 2017 and is headquartered in San Carlos, United States. A platform for whole-genome sequencing is offered in the genomics sector to calculate genome risk scores. These scores are used to evaluate risks for common conditions such as heart disease and complex rare disorders influenced by multiple genetic elements. Drug response insights are also generated. Additionally, whole-genome analysis services are available for embryo selection during IVF procedures.
Who are the top competitors of MyOme?
MyOme's top competitors include Dante Labs, InformedDNA and Muhdo.
What products or services does MyOme offer?
MyOme offers Proactive Health Tests, Diagnostic Tests, and Integrated Polygenic Risk Score.
Who are MyOme's investors?
MyOme has 1 investor. Key investors include Healthcare Ventures.